EpiVario Raises $445K in Seed Funding to Develop a Novel Drug to Treat Post-Traumatic Stress Disorder (PTSD) at the Source of the Disease

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2EjpeFc
via IFTTT